BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025
BioNTech SE (Nasdaq: BNTX) has announced it will release its fourth quarter and full year 2024 financial results on Monday, March 10, 2025. The company will host a conference call and webcast at 8:00 a.m. EDT (1:00 p.m. CET) on the same day.
Investors, financial analysts, and the public can participate in the conference call by registering through a provided link to receive dial-in numbers and a PIN. The presentation slides and webcast audio will be accessible through another link and the company's website. A replay of the webcast will be available for 30 days after the call on BioNTech's website.
BioNTech SE (Nasdaq: BNTX) ha annunciato che pubblicherà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 lunedì 10 marzo 2025. L'azienda ospiterà una conferenza telefonica e un webcast alle 8:00 EDT (13:00 CET) lo stesso giorno.
Investitori, analisti finanziari e il pubblico possono partecipare alla conferenza telefonica registrandosi tramite un link fornito per ricevere i numeri di accesso e un PIN. Le diapositive della presentazione e l'audio del webcast saranno accessibili tramite un altro link e il sito web dell'azienda. Una registrazione del webcast sarà disponibile per 30 giorni dopo la chiamata sul sito di BioNTech.
BioNTech SE (Nasdaq: BNTX) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 el lunes 10 de marzo de 2025. La compañía llevará a cabo una llamada de conferencia y un webcast a las 8:00 a.m. EDT (1:00 p.m. CET) el mismo día.
Los inversores, analistas financieros y el público pueden participar en la llamada de conferencia registrándose a través de un enlace proporcionado para recibir los números de marcación y un PIN. Las diapositivas de la presentación y el audio del webcast estarán disponibles a través de otro enlace y en el sitio web de la compañía. Una repetición del webcast estará disponible durante 30 días después de la llamada en el sitio web de BioNTech.
BioNTech SE (Nasdaq: BNTX)는 2024년 4분기 및 연간 재무 결과를 2025년 3월 10일 월요일에 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 8시 EDT(오후 1시 CET)에 컨퍼런스 콜 및 웹캐스트를 진행할 예정입니다.
투자자, 금융 분석가 및 일반 대중은 제공된 링크를 통해 등록하여 전화 접속 번호와 PIN을 받을 수 있습니다. 발표 슬라이드와 웹캐스트 오디오는 다른 링크와 회사 웹사이트를 통해 접근할 수 있습니다. 웹캐스트의 재생은 BioNTech 웹사이트에서 통화 후 30일 동안 이용 가능합니다.
BioNTech SE (Nasdaq: BNTX) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 le lundi 10 mars 2025. L'entreprise organisera une conférence téléphonique et un webcast à 8h00 EDT (13h00 CET) le même jour.
Les investisseurs, analystes financiers et le public peuvent participer à la conférence téléphonique en s'inscrivant via un lien fourni pour recevoir les numéros de connexion et un PIN. Les diapositives de présentation et l'audio du webcast seront accessibles via un autre lien et le site web de l'entreprise. Un enregistrement du webcast sera disponible pendant 30 jours après l'appel sur le site de BioNTech.
BioNTech SE (Nasdaq: BNTX) hat angekündigt, dass es am Montag, den 10. März 2025 seine Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 8:00 Uhr EDT (13:00 Uhr CET) eine Telefonkonferenz und einen Webcast abhalten.
Investoren, Finanzanalysten und die Öffentlichkeit können an der Telefonkonferenz teilnehmen, indem sie sich über einen bereitgestellten Link registrieren, um Einwahlnummern und eine PIN zu erhalten. Die Präsentationsfolien und der Webcast-Audio werden über einen anderen Link und die Website des Unternehmens zugänglich sein. Eine Aufzeichnung des Webcasts wird 30 Tage nach dem Anruf auf der Website von BioNTech verfügbar sein.
- None.
- None.
MAINZ, Germany, February 24, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the fourth quarter and full year 2024 on Monday, March 10, 2025. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EDT (1:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update.
To access the live conference call via telephone, please register via this link. Once registered, dial-in numbers and a PIN will be provided. It is recommended to register at least one day in advance. The slide presentation and audio of the webcast will be available via this link.
Participants may also access the slides and the webcast of the conference call via the “Events & Presentations” page in the Investor Relations section of the Company’s website at www.BioNTech.com. A replay of the webcast will be made available shortly after the call and archived on the Company’s website for 30 days following the call.
About BioNTech
Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases. BioNTech exploits a wide array of computational discovery and therapeutic drug platforms with the intent of rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor (CAR) T cells, several protein-based therapeutics, including bispecific immune checkpoint modulators, targeted cancer antibodies and antibody-drug conjugate (ADC) therapeutics, as well as small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are researching and developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global and specialized pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, Genevant, Genmab, MediLink, OncoC4, Pfizer and Regeneron.
For more information, please visit www.BioNTech.com.
CONTACTS
Investor Relations
Michael Horowicz
Investors@biontech.de
Media Relations
Jasmina Alatovic
Media@biontech.de
FAQ
When will BioNTech (BNTX) report Q4 and full year 2024 earnings?
What time is BioNTech's (BNTX) Q4 2024 earnings call?
How can investors access BioNTech's (BNTX) Q4 2024 earnings call?
How long will BioNTech's (BNTX) Q4 2024 earnings call replay be available?
